1	8230022	rs438650	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
1	24187123	rs78312791	C	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
1	24970693	rs11249215	G	A	Ankylosing spondylitis;Psoriasis or type 2 diabetes (trans-disease meta-analysis)
1	63643011	rs2269242	G	A,T	Type 1 diabetes
1	67247663	rs113935720	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis)
1	67259437	rs10889677	C	A	Ulcerative colitis
1	152617711	rs6677595	C	G,T	Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis
1	155157915	rs4971079	G	A,C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
1	173399532	rs1578624	C	T	Systemic lupus erythematosus
2	60845432	rs35741374	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis)
2	65474623	rs840967	C	A,T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
2	73973913	rs10166809	C	T	Systemic lupus erythematosus
2	102055220	rs4851536	T	G	Endometriosis or asthma (pleiotropy)
2	164694691	rs7607980	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
2	190549137	rs34825614	A	G	Systemic lupus erythematosus
2	191047814	rs12465689	C	A,T	Systemic lupus erythematosus
2	191153045	rs897200	T	C	Behcet's disease
3	16969982	rs3906814	C	G,T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis)
3	56919146	rs9844930	A	C	Multiple sclerosis
3	101898138	rs771576	T	A,C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis)
3	185806293	rs4686392	A	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
4	7183972	rs3936663	A	C,T	Crohn's disease (time to first abdominal surgery)
4	101801236	rs4699259	C	A	Lupus nephritis in systemic lupus erythematosus
4	179363660	rs6811556	T	A,C	Ulcerative colitis
4	181478542	rs7672826	G	A	Multiple sclerosis
4	183688220	rs10018951	C	T	Systemic lupus erythematosus
5	96784466	rs39841	G	A,C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
5	151085018	rs75851973	A	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
5	151098757	rs17728338	G	A	Cutaneous psoriasis;Psoriasis
5	151107634	rs4958895	A	T	Systemic lupus erythematosus
6	29290190	rs1033568	G	A,T	Systemic lupus erythematosus
6	31285148	rs12191877	C	T	Psoriasis
6	31287231	rs13214872	C	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
6	32224440	rs16869875	C	T	Systemic lupus erythematosus
6	32359144	rs9268310	T	C	Systemic lupus erythematosus
6	32445274	rs3135388	A	G	Multiple sclerosis
6	32452182	rs3135384	A	G	Systemic lupus erythematosus
6	32591987	rs9270539	T	C	Systemic lupus erythematosus
6	32620208	rs9271429	A	G	Systemic lupus erythematosus
6	32699886	rs9275349	G	C	Systemic lupus erythematosus
6	32898318	rs9276916	A	G,T	Systemic lupus erythematosus
6	33066800	rs34596699	C	A,T	Systemic lupus erythematosus
6	33341335	rs184722928	G	A	Systemic lupus erythematosus
6	34584135	rs205284	C	G,T	Systemic lupus erythematosus
6	34747063	rs146761142	A	G	Systemic lupus erythematosus
6	34872621	rs3734261	G	A	Systemic lupus erythematosus
6	35056706	rs78368810	C	G	Systemic lupus erythematosus
6	137876687	rs582757	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis
7	105500705	rs6957263	T	C	Systemic lupus erythematosus
7	110352114	rs34723276	T	C	Multiple sclerosis
8	11486171	rs2254546	A	G	Kawasaki disease;Systemic lupus erythematosus
9	22081398	rs10116277	G	T	Endometriosis or asthma (pleiotropy)
9	32523739	rs11795343	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis;Psoriasis vulgaris
9	37037979	rs1329568	T	A,G	Response to tocilizumab in rheumatoid arthritis
9	75984217	rs6560480	C	T	Takayasu arteritis
10	73841838	rs2459446	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
10	100251454	rs12265333	A	G,T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
10	119246715	rs17098586	T	A	Coronary artery aneurysm in Kawasaki disease
10	133537633	rs2070676	G	C	Gout
11	64344456	rs685870	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
11	67104849	rs34560402	C	T	Osteoarthritis (with total hip replacement)
11	110091706	rs4561177	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis;Psoriasis vulgaris
11	128540369	rs10893884	T	A,C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
12	56347444	rs57137641	G	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
14	35383280	rs12884468	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis;Psoriasis vulgaris
16	30995651	rs2199036	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
16	58293742	rs2288012	A	G	Systemic lupus erythematosus
17	27797882	rs28998802	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis;Psoriasis vulgaris
17	42666566	rs2292749	C	A,T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
17	49334880	rs1343795	C	A	Egg allergy (maternal genetic effects)
19	54713283	rs2296370	A	G,T	Killer cell immunoglobulin-like receptor 2DL4 levels
19	54834954	rs4806584	T	A	Killer cell immunoglobulin-like receptor 2DL4 levels
19	54862632	rs77637758	T	C	Killer cell immunoglobulin-like receptor 2DL4 levels
19	54866128	rs3745900	T	C	Killer cell immunoglobulin-like receptor 2DL4 levels
19	54867770	rs12459411	C	T	Killer cell immunoglobulin-like receptor 2DL4 levels
19	54878590	rs181695385	T	C	Killer cell immunoglobulin-like receptor 2DL4 levels
19	54908874	rs8111853	G	T	Killer cell immunoglobulin-like receptor 2DL4 levels
20	49974254	rs6063454	G	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis)
